An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Matthew Strother Daniela E. Matei |
| Publication date | September 26, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |